Human Tumor Sequencing Project (HuTS)

Scripps Translational Science Institute

Status: Completed

Conditions: Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT01608230

09-5270

Details and patient eligibility

About

This study is being done to learn more about genetic mutations in cancer cells and to find out how the development of new technologies can increase knowledge of these mutations and possibly predict an individual's response to certain treatments.

Enrollment: 35 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Diagnosis of a solid tumor or blood borne cancer
• 18 years or older
• Eligible to have blood drawn